Request for Covid-19 Impact Assessment of this Report

Food and Beverages

Europe Prebiotics for Infant Formula Market - Industry Trends and Forecast To 2027

  • DAT3435556
  • 130 Pages
  • December 2019
  • Food and Beverages
Download Sample    Get Discount   
 
Europe prebiotics for infant formula market is projected to register a substantial CAGR of in the forecast period of 2020 to 2027. The new market report contains data for the historic years 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), By Country (Germany, U.K., France, Italy, Spain, Denmark, Netherlands, Switzerland, Poland, Russia, Sweden, Belgium, Turkey and Rest of Europe), Market Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Europe prebiotics for infant formula market:

 Rising Number from Preterm/Premature Babies

 Increased Research Initiative for new product development

Market Players:

The key market players for Europe prebiotics for infant formula market are listed below:

• Jennewein Biotechnologie GmbH

• zuChem Inc

• Biosynth Carbosynth

• Elicityl SA Dextra Laboratories Limited

• Glycom A/S

• Tereos

• Ingredion Incorporated

• Royal FrieslandCampina N.V

• Südzucker AG

• Cargill, Incorporated

• Fonterra Co-operative Group

• Royal Cosun

• COSUCRA

• New Francisco (Yunfu City) Biotechnology Corporation Limited

• Dana Dairy Group

• Glycosyn LLC

• DuPont

TABLE OF CONTENTS

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE PREBIOTICS FOR INFANT FORMULA MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 MULTIVARIATE MODELING

2.8 PRODUCT TIMELINE CURVE

2.9 SECONDARY SOURCES

2.10 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 EVOLUTION

5.1 EVOLUTION OF INFANT FORMULA

5.2 EVOLUTION OF PREBIOTICS FORMULA

6 REGULATIONS & QUALITY REQUIREMENTS

6.1 REGULATIONS

6.1.1 FDA

6.1.1.1 GRAS NOTICE NO. GRN 000849

6.1.1.2 GRAS NOTICE NO. GRN 00859

6.1.1.3 GRAS NOTICE NO. GRN 000797

6.1.1.4 GRAS NOTICE NO. GRN 000766

6.1.1.5 GRAS NOTICE NO. GRN 000749

6.1.1.6 GRAS NOTICE NO. GRN 000735

6.1.1.7 GRAS NOTICE NO. GRN 000729

6.1.1.8 GRAS NOTICE NO. GRN 000717

6.1.1.9 GRAS NOTICE NO. GRN 000721

6.1.1.10 GRAS NOTICE NO. GRN 000659

6.1.1.11 GRAS NOTICE NO. GRN 000650

6.1.1.12 GRAS NOTICE NO. GRN 000623

6.1.1.13 GRAS NOTICE NO. GRN 000620

6.1.2 EUROPEAN UNION

6.1.2.1 COMMISSION DIRECTIVE 2006/141/EC

6.1.3 AUSTRALIA NEW ZEALAND FOOD STANDARDS CODE

6.1.3.1 STANDARD 2.9.1

6.1.3.2 STANDARD 2.9.2

6.1.3.3 STANDARD 2.9.3

6.2 QUALITY REQUIREMENTS

7 CLINICAL TRIALS

7.1 NCT03994315

7.2 NCT03884309

7.3 NCT02594683

7.4 NCT03661736

7.5 NCT03666572

7.6 NCT03866837

7.7 NCT03476889

8 INFANT FORMULA BRAND ANALYSTS

8.1 ABBOTT

8.2 MEAD JOHNSON & COMPANY, LLC

8.3 DANONE NUTRICIA

8.4 NESTLE

8.5 PERRIGO NUTRITIONALS

8.6 HOCHDORF HOLDING AG

9 MARKET OVERVIEW

9.1 DRIVERS

9.1.1 RISING NUMBER FROM PRETERM/PREMATURE BABIES

9.1.2 INCREASED RESEARCH INITIATIVE FOR NEW PRODUCT DEVELOPMENT

9.1.3 HEALTH BENEFITS ASSOCIATED WITH PREBIOTICS

9.1.4 GROWING CONCERN AND DEMAND FOR THE HEALTHY BABY FOOD

9.1.5 RISING POPULATION OF INFANT

9.2 RESTRAINTS

9.2.1 STRINGENT REGULATION AND APPROVAL CRITERIA SET BY GOVERNMENTS

9.2.2 RISING AWARENESS TOWARDS MOTHER FEEDING FOR INFANT

9.3 OPPORTUNITIES

9.3.1 RAPID DEVELOPMENT IN CHICORY ROOT BASED PREBIOTICS

9.3.2 EMERGING DEMAND IN DEVELOPING NATIONS

9.3.3 STRENGTHENING TRADE RELATIONSHIP BETWEEN DIFFERENT NATIONS

9.4 CHALLENGE

9.4.1 RISING NUMBER OF PRODUCT RECALLS FOR INFANT FORMULA DUE TO CONTAMINATION

10 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE

10.1 OVERVIEW

10.2 HUMAN MILK OLIGOSACCHARIDES (HMOS)

10.2.1 FUCOSYLLACTOSE

10.2.1.1 NEUTRAL FUCOSYLATE OLIGOSACCHARIDES

10.2.1.2 NON-FUCOSYLATED OLIGOSACCHARIDES

10.2.2 LACTO-N- TETRAOSE (LNT) & LACTO-N-NEOTETRAOSE (LNNT)

10.2.3 SIALYLLACTOSE

10.3 FRUCTOOLIGOSACCHARIDES (FOS)

10.3.1 LONG CHAIN FOS (LCFOS)

10.3.2 SINGLE CHAIN FOS (SCFOS)

10.4 GALACTOOLIGOSACCHARIDES (GOS)

10.4.1 LACTOSE DERIVED

10.4.2 GALACTOSE DERIVED

10.5 INULIN

10.6 POLYDEXTROSE (PDX)

10.7 MANNAN-OLIGOSACCHARIDES (MOS)

10.8 LACTULOSE (LOS)

11 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE

11.1 OVERVIEW

11.2 PLANTS & VEGETABLES

11.2.1 WHEAT

11.2.2 CHICORY ROOT

11.2.3 BANANAS

11.2.4 LEEKS

11.2.5 TOMATOES

11.2.6 OTHERS

11.3 BACTERIA

11.4 FUNGI

11.5 ALGAE

11.6 OTHERS

12 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE

12.1 OVERVIEW

12.2 INORGANIC

12.3 ORGANIC

13 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM

13.1 OVERVIEW

13.2 POWDER

13.3 LIQUID

14 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE

14.1 OVERVIEW

14.2 STANDARD FORMULA

14.3 SPECIAL FORMULA

14.4 FOLLOW UP FORMULA

14.5 TODDLER FORMULA

15 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE

15.1 OVERVIEW

15.2 6-12 MONTHS

15.3 0-6 MONTHS

15.4 1-3 YEARS

16 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY GEOGRAPHY

16.1 EUROPE

16.1.1 GERMANY

16.1.2 U.K.

16.1.3 FRANCE

16.1.4 ITALY

16.1.5 SPAIN

16.1.6 DENMARK

16.1.7 NETHERLANDS

16.1.8 SWITZERLAND

16.1.9 POLAND

16.1.10 RUSSIA

16.1.11 SWEDEN

16.1.12 BELGIUM

16.1.13 TURKEY

16.1.14 REST OF EUROPE

17 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: EUROPE

18 COMPANY PROFILE

18.1 ROYAL FRIESLANDCAMPINA N.V.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 CARGILL, INCORPORATED.

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 COMPANY SHARE ANALYSIS

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENT

18.3 INGREDION INCORPORATED

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENT

18.4 BENEO (A SUBSIDIARY OF SÜDZUCKER)

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 FONTERRA CO-OPERATIVE GROUP

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 BIOSYNTH CARBOSYNTH

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENTS

18.7 COSUCRA

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 DANA DAIRY GROUP

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 DEXTRA LABORATORIES LIMITED

18.9.1 COMPANY SNAPSHOT

18.9.2 PRODUCT PORTFOLIO

18.9.3 RECENT DEVELOPMENT

18.10 DUPONT.

18.10.1 COMPANY SNAPSHOT

18.10.2 REVENUE ANALYSIS

18.10.3 PRODUCT PORTFOLIO

18.10.4 RECENT DEVELOPMENTS

18.11 ELICITYL SA

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENT

18.12 GLYCOM A/S

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENT

18.13 GLYCOSYN LLC.

18.13.1 COMPANY SNAPSHOT

18.13.2 PRODUCT PORTFOLIO

18.13.3 RECENT DEVELOPMENTS

18.14 JENNEWEIN BIOTECHNOLOGIE GMBH

18.14.1 COMPANY SNAPSHOT

18.14.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENTS

18.15 NEW FRANCISCO (YUNFU CITY) BIOTECHNOLOGY CORPORATION LIMITED

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENTS

18.16 ROYAL COSUN

18.16.1 COMPANY SNAPSHOT

18.16.2 REVENUE ANALYSIS

18.16.3 APPLICATION PORTFOLIO

18.16.4 RECENT DEVELOPMENT

18.17 TEREOS

18.17.1 COMPANY SNAPSHOT

18.17.2 REVENUE ANALYSIS

18.17.3 PRODUCT PORTFOLIO

18.17.4 RECENT DEVELOPMENT

18.18 ZUCHEM INC.

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF TABLES

UU

TABLE 1 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 3 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 4 EUROPE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 EUROPE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 EUROPE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 7 EUROPE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 EUROPE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 9 EUROPE INULIN IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 EUROPE POLYDEXTROSE (PDX) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 EUROPE MANNAN-OLIGOSACCHARIDES (MOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 EUROPE LACTULOSE (LOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 14 EUROPE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 EUROPE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 16 EUROPE BACTERIA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 EUROPE FUNGI IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 EUROPE ALGAE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 EUROPE OTHERS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 21 EUROPE INORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 EUROPE ORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 24 EUROPE POWDER IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 EUROPE LIQUID IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 27 EUROPE STANDARD FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 EUROPE SPECIAL FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 EUROPE FOLLOW UP FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 EUROPE TODDLER FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 32 EUROPE 6-12 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 EUROPE 0-6 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 EUROPE 1-3 YEARS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 35 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 36 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 37 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 38 EUROPE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 39 EUROPE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 40 EUROPE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 41 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 42 EUROPE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 43 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 44 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 45 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 46 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 47 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 48 GERMANY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 GERMANY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 GERMANY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 GERMANY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 53 GERMANY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 54 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 55 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 56 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 57 GERMANY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 58 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 U.K. HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 U.K. FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 61 U.K. GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 62 U.K. FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 63 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 64 U.K. PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 65 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 66 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 67 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 68 U.K. PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 69 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 70 FRANCE HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 71 FRANCE FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 72 FRANCE GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 73 FRANCE FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 74 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 75 FRANCE PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 76 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 77 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 78 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 79 FRANCE PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 80 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 81 ITALY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 82 ITALY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 83 ITALY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 84 ITALY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 85 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 86 ITALY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 87 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 88 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 89 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 90 ITALY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 91 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 92 SPAIN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 93 SPAIN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 94 SPAIN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 95 SPAIN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 96 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 97 SPAIN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 98 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 99 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 100 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 101 SPAIN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 102 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 103 DENMARK HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 104 DENMARK FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 105 DENMARK GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 106 DENMARK FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 107 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 108 DENMARK PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 109 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 110 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 111 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 112 DENMARK PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 113 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 114 NETHERLANDS HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 115 NETHERLANDS FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 116 NETHERLANDS GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 117 NETHERLANDS FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 118 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 119 NETHERLANDS PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 120 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 121 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 122 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 123 NETHERLANDS PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 124 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 125 SWITZERLAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 126 SWITZERLAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 127 SWITZERLAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 128 SWITZERLAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 129 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 130 SWITZERLAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 131 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 132 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 133 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 134 SWITZERLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 135 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 136 POLAND HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 137 POLAND FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 138 POLAND GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 139 POLAND FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 140 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 141 POLAND PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 142 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 143 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 144 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 145 POLAND PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 146 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 147 RUSSIA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 148 RUSSIA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 149 RUSSIA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 150 RUSSIA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 151 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 152 RUSSIA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 153 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 154 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 155 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 156 RUSSIA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 157 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 158 SWEDEN HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 159 SWEDEN FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 160 SWEDEN GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 161 SWEDEN FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 162 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 163 SWEDEN PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 164 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 165 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 166 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 167 SWEDEN PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 168 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 169 BELGIUM HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 170 BELGIUM FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 171 BELGIUM GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 172 BELGIUM FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 173 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 174 BELGIUM PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 175 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 176 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 177 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 178 BELGIUM PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 179 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 180 TURKEY HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 181 TURKEY FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 182 TURKEY GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 183 TURKEY FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 184 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 185 TURKEY PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 186 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)

TABLE 187 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 188 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 189 TURKEY PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)

TABLE 190 REST OF EUROPE PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Risk Evaluation of China's Beer Industry 2014-2019

Driven by improving living standards of people and a fast-growing macro-economy, China has remained the largest beer-consuming country worldwide for the 12th consecutive year since 2003, and the largest beer-producing nation globally in the past years. This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (ar...

  • Publish Date: November 26, 2014
  • $800
Global Protein-based Fat Replacers Market 2012- 2022

Summary Based on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type Microparticulated Protein Modified Whey Protein Concentrate Others Based on region, the report describes major regions market by vendor, products and application. Regions mentioned as follows: North America Europe Asia RoW Based on application, the repor...

  • Publish Date: March 1, 2017
  • $840
Global Oat Protein Market Research 2011- 2022

Summary The global Oat Protein market is estimated to reach 1.4 K MT in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regio...

  • Publish Date: April 15, 2017
  • $840